The
aim of this study is to study whether a medication called Droperidol, can be
absorbed effectively using an intranasal spray. Droperidol, administered
intravenously or by injection, is approved in Australia as an
antipsychotic, to treat acute behavioural disturbance (ABD) and nausea and
vomiting. Further details are attached here.
If
you are interested in participating in this study, please contact a study
researcher (Professor Andis Graudins or Dr Isabelle Cooper) on 9554-9340 or email
andis.graudins@monashhealth.org.
No comments:
Post a Comment